▁Chron 9.296875
ic 0.548828125
▁pain 2.759765625
▁is 1.1630859375
▁still 6.71875
▁considered 3.98828125
▁to 1.927734375
▁be 0.032806396484375
▁an 2.6796875
▁extreme 7.26171875
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.15576171875
▁ 0.390380859375
8 3.47265625
% 2.19140625
▁of 0.122314453125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.319580078125
▁countries 0.91650390625
. 0.63525390625
▁The 2.115234375
▁introduction 7.74609375
▁of 0.0309906005859375
▁the 2.357421875
▁study 7.31640625
▁describes 7.28515625
▁the 0.5732421875
▁apparent 8.9140625
▁link 4.6796875
▁between 0.2406005859375
▁pain 2.71875
▁and 0.2958984375
▁dem 7.14453125
oral 3.390625
ization 0.12353515625
. 1.046875
▁Chron 4.515625
ic 0.0032253265380859375
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.6015625
▁accompanied 2.982421875
▁by 0.1500244140625
▁negative 4.1484375
▁emot 0.9111328125
ional 1.4072265625
▁experiences 2.984375
▁and 2.080078125
▁blocks 11.3046875
▁a 3.33984375
▁person 0.69140625
’ 0.876953125
s 0.0010728836059570312
▁ability 1.3876953125
▁to 0.037200927734375
▁receive 6.84375
▁joy 3.728515625
▁and 1.376953125
▁satisfaction 3.25390625
▁from 0.86767578125
▁life 0.79443359375
. 0.2281494140625
▁The 1.6455078125
▁research 2.693359375
▁investig 5.40625
ates 0.3876953125
▁the 0.38818359375
▁development 6.15234375
▁of 0.145751953125
▁de 3.83984375
pression 0.45849609375
▁and 1.357421875
▁anx 1.6201171875
iety 0.0010986328125
▁among 1.603515625
▁patients 1.4833984375
▁receiving 5.83203125
▁ph 5.4765625
arma 3.240234375
ce 0.01218414306640625
ut 6.61611557006836e-05
ical 0.006450653076171875
▁op 4.64453125
io 0.097900390625
ids 0.440185546875
▁and 2.4921875
▁medical 4.0546875
▁mar 1.744140625
iju 0.0010824203491210938
ana 4.839897155761719e-05
▁( 2.96484375
MM 1.2998046875
) 2.884765625
▁as 2.44140625
▁severe 9.984375
▁pain 0.7822265625
kill 2.658203125
ers 0.0005207061767578125
. 0.21630859375
▁It 3.2578125
▁comp 4.984375
ares 0.0084686279296875
▁the 0.58935546875
▁effic 4.296875
acy 0.0018758773803710938
▁of 0.2064208984375
▁pres 6.0859375
cri 1.9169921875
ptions 1.451171875
▁and 1.9296875
▁exam 4.49609375
ines 0.00980377197265625
▁the 0.473388671875
▁possibility 3.95703125
▁of 0.132080078125
▁post 8.203125
- 0.58740234375
tre 1.96875
at 0.001781463623046875
ment 0.004730224609375
▁de 1.6416015625
pression 0.08135986328125
. 1.384765625
▁There 5.67578125
▁is 1.146484375
▁currently 6.203125
▁a 1.1640625
▁severe 5.1171875
▁lack 1.6416015625
▁of 0.0124969482421875
▁information 2.236328125
▁about 1.205078125
▁the 0.58447265625
▁effects 3.2109375
▁of 0.06561279296875
▁op 3.447265625
i 3.546875
ates 0.01343536376953125
. 3.322265625
▁They 5.28515625
▁manage 8.640625
▁pain 3.125
▁successfully 5.80859375
, 0.9716796875
▁but 0.19140625
▁the 2.4609375
▁past 9.1484375
▁few 2.455078125
▁dec 1.341796875
ades 0.0011491775512695312
▁indicated 7.15625
▁the 1.765625
▁growing 3.634765625
▁concern 3.36328125
▁regarding 2.779296875
▁op 2.6796875
iate 1.224609375
▁ab 1.5693359375
use 0.0152587890625
▁in 3.92578125
▁forms 8.90625
▁of 0.251708984375
▁over 3.2265625
d 0.1046142578125
ose 0.30859375
▁and 0.6953125
▁add 0.70361328125
iction 0.01995849609375
. 0.12054443359375
▁A 4.25390625
▁more 4.91796875
▁manage 7.9453125
able 0.0005421638488769531
▁and 2.013671875
▁sa 2.0625
fer 0.00016701221466064453
▁alternative 1.3134765625
▁might 5.078125
▁be 0.1187744140625
▁medical 1.8916015625
▁mar 0.18603515625
iju 0.0006275177001953125
ana 9.906291961669922e-05
. 0.849609375
▁However 3.68359375
, 0.0031299591064453125
▁the 1.703125
▁legal 4.015625
▁status 1.1298828125
▁and 3.017578125
▁novel 9.7109375
ty 0.1376953125
▁of 0.1502685546875
▁this 2.287109375
▁drug 1.40625
▁do 4.40234375
▁not 0.01220703125
▁allow 0.673828125
▁finding 6.98828125
▁a 2.35546875
▁large 2.541015625
▁number 0.81005859375
▁of 0.0022735595703125
▁studies 1.302734375
▁on 1.7568359375
▁its 0.81005859375
▁effect 2.3984375
iveness 0.202392578125
. 0.6416015625
▁Specifically 8.96875
, 0.03997802734375
▁it 2.6171875
▁concerns 5.26171875
▁the 0.8095703125
▁emot 6.42578125
ional 0.018218994140625
▁condition 4.58203125
▁of 0.221923828125
▁patients 0.65234375
▁experien 5.3046875
cing 0.0001722574234008789
▁chron 0.8134765625
ic 0.00037097930908203125
▁pain 0.05133056640625
. 0.378173828125
▁This 3.0078125
▁research 1.814453125
▁paper 3.951171875
▁a 2.013671875
ims 0.0005292892456054688
▁to 0.10504150390625
▁analyze 3.19140625
▁levels 10.1484375
▁of 0.0240936279296875
▁de 0.5185546875
pression 0.0250091552734375
▁and 0.1856689453125
▁anx 0.0253753662109375
iety 0.0004305839538574219
▁among 0.7451171875
▁people 2.6796875
▁receiving 2.25
▁ther 6.625
apy 0.111572265625
▁by 4.5546875
▁comparing 8.3671875
▁the 1.5078125
▁effects 2.19140625
▁of 0.0268402099609375
▁ph 2.841796875
arma 0.0309906005859375
ce 0.0027313232421875
ut 0.00010335445404052734
ical 0.003261566162109375
▁op 0.11114501953125
io 0.4873046875
ids 0.031982421875
▁and 0.255615234375
▁MM 0.509765625
. 0.287841796875
▁The 1.4736328125
▁study 2.00390625
▁was 3.544921875
▁conducted 0.70947265625
▁in 1.3017578125
▁the 1.3779296875
▁form 2.580078125
▁of 0.0020885467529296875
▁collection 11.625
▁and 0.70068359375
▁analysis 0.411865234375
▁of 0.0103302001953125
▁statistical 3.748046875
▁data 0.1298828125
. 1.1982421875
▁The 0.931640625
▁research 1.9814453125
ers 2.048828125
▁used 1.58984375
▁The 7.3828125
▁De 2.892578125
pression 0.0221710205078125
▁Module 7.08984375
▁of 0.96240234375
▁the 0.27734375
▁Pat 2.201171875
ient 0.004711151123046875
▁Health 0.04827880859375
▁Question 0.017578125
naire 0.0216064453125
▁and 2.501953125
▁the 0.84130859375
▁General 0.966796875
ized 0.61083984375
▁An 0.004131317138671875
x 7.593631744384766e-05
iety 0.00048160552978515625
▁Dis 0.190673828125
order 0.0190582275390625
▁Sc 1.5556640625
ale 0.00307464599609375
▁to 1.111328125
▁interview 8.2265625
▁participants 2.99609375
, 4.421875
▁evaluate 4.796875
▁their 0.60546875
▁answers 3.63671875
, 0.3125
▁and 0.039154052734375
▁conduct 4.86328125
▁the 1.78515625
▁study 2.82421875
. 0.0992431640625
▁Part 5.57421875
icip 0.08575439453125
ants 0.052978515625
▁were 0.87158203125
▁rec 3.9609375
ru 0.0016584396362304688
ited 6.42538070678711e-05
▁for 4.59765625
▁six 6.734375
▁months 0.306396484375
▁at 3.708984375
▁two 2.4375
▁major 4.171875
▁pain 2.400390625
▁relief 4.31640625
▁cent 0.8837890625
ers 0.0272979736328125
▁in 0.5703125
▁Israel 5.36328125
. 0.322265625
▁To 5.1875
▁specifically 10.46875
▁evaluate 3.076171875
▁and 5.0234375
▁compare 0.537109375
▁the 0.38720703125
▁prob 9.8359375
abilities 0.083740234375
▁of 0.0711669921875
▁de 0.861328125
pression 0.034576416015625
▁or 4.3125
▁anx 0.041290283203125
iety 0.0005369186401367188
▁among 1.3564453125
▁the 2.140625
▁diverse 9.6171875
▁groups 0.89111328125
, 0.74853515625
▁the 0.4736328125
▁study 2.291015625
▁used 1.5859375
▁multiple 5.296875
▁log 0.8046875
istic 0.0245208740234375
▁regression 0.281494140625
▁analysis 1.3447265625
▁and 2.748046875
▁chose 8.3984375
▁medical 6.171875
▁mar 0.1036376953125
iju 0.0007534027099609375
ana 4.184246063232422e-05
▁as 0.5400390625
▁the 0.82861328125
▁control 2.654296875
▁group 0.58544921875
. 0.243896484375
▁This 3.599609375
▁type 4.48828125
▁of 0.0043792724609375
▁study 2.80859375
▁is 1.52734375
▁the 3.744140625
▁most 1.4091796875
▁reve 8.2265625
aling 0.0007853507995605469
▁and 1.5673828125
▁inclus 7.18359375
ive 0.0009751319885253906
, 2.5703125
▁as 1.2421875
▁it 0.268310546875
▁contains 5.15625
▁direct 6.80078125
▁responses 5.625
▁from 0.83447265625
▁a 3.634765625
▁large 1.18359375
▁number 0.51416015625
▁of 0.002811431884765625
▁participants 1.0537109375
. 0.74658203125
▁All 5.3359375
▁tools 8.1640625
▁in 5.1796875
▁the 0.60400390625
▁form 5.3359375
▁of 0.024078369140625
▁question 0.6708984375
na 0.0115814208984375
ires 0.00016415119171142578
▁and 1.48828125
▁scales 2.828125
▁have 3.310546875
▁already 4.3671875
▁been 0.34765625
▁used 2.388671875
▁and 1.826171875
▁proved 2.490234375
▁their 1.4306640625
▁effic 2.576171875
acy 0.0028095245361328125
▁for 3.5859375
▁collect 4.03125
ing 0.00406646728515625
▁analyt 7.25
ical 0.0947265625
▁data 0.1898193359375
. 0.380859375
▁It 3.7578125
▁helps 4.32421875
▁to 0.623046875
▁system 6.66796875
at 0.6220703125
ize 0.0018291473388671875
▁and 1.2646484375
▁class 4.78125
ify 0.0016584396362304688
▁distinct 8.1953125
▁kinds 6.359375
▁of 0.0165557861328125
▁information 2.154296875
▁for 3.98046875
▁subsequent 5.046875
▁un 8.6328125
comp 4.17578125
licated 0.02056884765625
▁services 12.3671875
. 0.576171875
▁Thus 4.79296875
, 0.0074615478515625
▁research 4.6796875
ers 0.347900390625
▁can 1.6650390625
▁compare 2.658203125
▁the 0.96630859375
▁effects 2.943359375
▁of 0.10308837890625
▁medic 3.8046875
ations 0.658203125
▁on 1.53515625
▁patients 2.025390625
▁of 4.296875
▁diverse 3.201171875
▁age 1.9794921875
▁groups 2.064453125
, 0.75537109375
▁background 3.873046875
s 0.11865234375
, 0.0156707763671875
▁physical 5.59765625
▁conditions 1.2978515625
, 0.034393310546875
▁emot 6.27734375
ional 0.0286865234375
▁states 1.2998046875
, 0.04046630859375
▁and 0.377685546875
▁so 2.70703125
▁on 0.193359375
. 0.0638427734375
▁The 0.9677734375
▁analysis 3.677734375
▁of 0.99072265625
▁any 8.65625
▁human 6.8203125
▁reaction 3.87890625
▁has 4.81640625
▁a 1.8359375
▁high 2.982421875
▁potential 3.1640625
▁of 2.29296875
▁subject 4.0859375
iveness 3.63671875
▁and 1.2119140625
▁bias 1.9599609375
, 1.6259765625
▁especially 2.755859375
▁regarding 3.669921875
▁people 4.8828125
▁in 3.693359375
▁severe 2.5
▁pain 0.56298828125
▁and 2.3671875
▁un 5.6171875
stable 0.91943359375
▁emot 0.69775390625
ional 0.0892333984375
▁condition 2.51171875
. 0.055145263671875
▁Perhaps 9.03125
▁some 5.38671875
▁patients 2.197265625
▁tend 4.5078125
▁to 0.00858306884765625
▁ex 1.96484375
agger 0.00806427001953125
ate 0.0013742446899414062
▁their 0.958984375
▁de 3.298828125
press 1.7041015625
ive 0.063720703125
▁state 2.509765625
▁or 1.6181640625
▁vice 5.62109375
▁vers 0.0231475830078125
a 2.7894973754882812e-05
, 1.0947265625
▁de 7.328125
- 2.544921875
emph 0.43017578125
as 0.00223541259765625
ize 0.05780029296875
▁serious 6.77734375
▁difficulties 5.56640625
. 0.77197265625
▁Because 6.328125
▁the 2.974609375
▁survey 4.95703125
▁responses 6.734375
▁were 1.5322265625
▁thoroughly 8.09375
▁anonymous 3.06640625
, 0.28076171875
▁the 1.19140625
▁research 1.0087890625
ers 0.19873046875
▁were 2.455078125
▁unable 3.333984375
▁to 0.0016155242919921875
▁carefully 7.92578125
▁analyze 2.654296875
▁each 2.421875
▁patient 2.486328125
’ 0.548828125
s 0.001102447509765625
▁reaction 3.9140625
▁and 1.390625
▁compare 3.75390625
▁it 0.83984375
▁to 0.61669921875
▁the 0.9697265625
▁actual 4.42578125
▁states 7.6171875
▁of 0.66943359375
▁condition 7.02734375
. 0.352783203125
▁However 2.431640625
, 0.0004658699035644531
▁this 2.197265625
▁method 3.28125
▁of 1.419921875
▁research 2.59375
▁is 1.3359375
▁way 9.0234375
▁more 0.2276611328125
▁resource 7.31640625
- 2.166015625
int 2.3671875
ensive 0.01462554931640625
▁and 0.70166015625
▁energy 11.390625
- 0.05816650390625
consum 0.5908203125
ing 0.0018768310546875
. 1.8291015625
▁More 5.8359375
▁accurate 4.40625
▁answers 4.03515625
▁could 2.470703125
▁be 0.42138671875
▁obtained 1.0029296875
▁by 1.2060546875
▁professional 5.70703125
▁psych 1.16015625
olog 0.334228515625
ists 0.001010894775390625
▁via 6.640625
▁personal 2.6796875
▁communication 4.15234375
▁and 1.8603515625
▁behavior 6.41015625
al 0.255126953125
▁analysis 1.966796875
. 0.2705078125
▁Part 6.33203125
icip 0.392822265625
ants 0.117919921875
▁were 1.35546875
▁rec 2.3984375
ru 0.0005211830139160156
ited 1.4066696166992188e-05
▁for 1.74609375
▁six 0.277587890625
▁months 0.004398345947265625
▁at 0.277587890625
▁two 0.050201416015625
▁major 0.06964111328125
▁pain 0.0268402099609375
▁relief 0.01910400390625
▁cent 0.01004791259765625
ers 0.0008368492126464844
▁in 0.038238525390625
▁Israel 0.0106048583984375
. 0.1607666015625
▁All 3.35546875
▁patients 2.0078125
▁experienced 4.484375
▁chron 0.85693359375
ic 0.00017499923706054688
▁pain 0.166748046875
▁for 2.515625
▁at 0.64404296875
▁least 0.0014734268188476562
▁ 1.8271484375
3 1.50390625
▁months 0.247314453125
. 1.27734375
▁The 1.4208984375
▁study 1.921875
▁included 1.6923828125
▁ 0.62646484375
8 3.03515625
9 2.533203125
0 3.12890625
▁participants 1.5380859375
, 1.4453125
▁of 2.697265625
▁which 0.43505859375
▁ 0.09893798828125
4 1.2109375
7 2.65625
4 2.607421875
▁( 3.13671875
5 0.0908203125
9 4.87109375
%) 0.77734375
▁were 0.7607421875
▁treated 3.228515625
▁sole 6.625
ly 8.320808410644531e-05
▁with 0.281494140625
▁op 1.33984375
io 0.319091796875
ids 0.1312255859375
, 0.50830078125
▁ 0.77197265625
3 1.240234375
2 2.236328125
9 2.466796875
▁( 0.043243408203125
4 2.5
1 1.1171875
%) 0.054779052734375
▁were 1.423828125
▁treated 0.52587890625
▁with 0.402587890625
▁MM 0.62158203125
, 0.37890625
▁and 0.099365234375
▁ 0.2203369140625
7 2.02734375
7 2.36328125
▁( 0.1025390625
8 1.9501953125
. 0.94921875
6 2.4296875
%) 0.07696533203125
▁acquired 10.46875
▁both 0.6298828125
▁( 4.73828125
Fe 9.5390625
ing 1.380859375
old 0.34619140625
▁et 0.98486328125
▁al 0.0213165283203125
., 0.1602783203125
▁ 0.01184844970703125
2 0.0061798095703125
0 0.00023496150970458984
1 0.37890625
7 1.7197265625
). 0.044586181640625
▁The 0.98583984375
▁remaining 7.984375
▁ten 6.73046875
▁participants 1.33203125
▁who 4.9296875
▁did 2.384765625
▁not 0.0062408447265625
▁receive 2.259765625
▁ph 3.91796875
arma 0.09893798828125
ce 0.0007905960083007812
ut 3.2186508178710938e-06
ical 0.002262115478515625
▁op 1.400390625
io 0.041839599609375
ids 0.0220794677734375
▁and 2.453125
▁medical 1.732421875
▁mar 0.039764404296875
iju 0.0002474784851074219
ana 4.124641418457031e-05
▁were 0.47021484375
▁with 6.76171875
dra 0.054534912109375
wn 4.863739013671875e-05
▁from 0.2442626953125
▁the 0.1922607421875
▁analysis 2.33984375
▁in 5.05078125
▁the 1.18359375
▁research 4.42578125
. 1.1142578125
▁Therefore 4.87890625
, 0.0144195556640625
▁it 3.740234375
▁is 1.2421875
▁not 2.84765625
▁possible 0.73193359375
▁to 0.007793426513671875
▁compreh 5.86328125
ens 0.1273193359375
ively 0.0169830322265625
▁compare 1.333984375
▁patients 5.04296875
▁taking 3.740234375
▁medic 4.10546875
ations 0.55029296875
▁with 1.4453125
▁those 1.06640625
▁who 0.76171875
▁do 1.404296875
▁not 0.004398345947265625
. 0.63134765625
▁The 1.431640625
▁study 1.8564453125
▁conducted 4.359375
▁a 1.7607421875
▁correlation 6.55859375
▁type 9.1328125
▁of 0.21533203125
▁research 0.89501953125
▁with 3.46875
▁variable 8.4921875
▁measures 5.09375
. 0.9375
▁It 1.6533203125
▁evaluated 5.12109375
▁the 0.5859375
▁inter 6.03515625
dep 2.3046875
end 0.00020813941955566406
ence 0.0076446533203125
▁of 0.59814453125
▁various 3.408203125
▁factors 0.9287109375
▁that 2.87109375
▁affected 4.1796875
▁the 0.433349609375
▁physical 6.3203125
▁and 0.281494140625
▁emot 0.464599609375
ional 0.00010526180267333984
▁condition 1.41796875
▁of 0.044891357421875
▁patients 0.7685546875
▁experien 3.001953125
cing 1.1920928955078125e-06
▁chron 0.22705078125
ic 0.00018358230590820312
▁pain 0.01157379150390625
. 0.1329345703125
▁For 4.2109375
▁example 1.1611328125
, 0.001583099365234375
▁the 1.0751953125
▁survey 5.5078125
▁showed 4.12890625
▁that 0.462158203125
▁the 1.8837890625
▁ratio 6.71484375
▁of 0.07867431640625
▁female 3.552734375
▁patients 0.93212890625
▁was 1.2568359375
▁remark 7.98046875
ably 0.0001614093780517578
▁higher 0.17822265625
▁in 2.4296875
▁the 0.466064453125
▁op 3.802734375
i 3.490234375
ates 0.01201629638671875
▁group 0.1981201171875
▁compared 2.48046875
▁to 0.042083740234375
▁the 0.61572265625
▁MM 0.154052734375
▁group 0.326904296875
. 0.444580078125
▁In 3.48046875
▁turn 4.30078125
, 0.0010843276977539062
▁people 4.96875
▁on 4.76953125
▁op 3.177734375
i 0.65380859375
ates 0.0034332275390625
▁were 0.9482421875
▁more 1.3740234375
▁likely 0.291015625
▁to 0.026031494140625
▁report 2.8828125
▁major 6.0078125
▁de 0.45654296875
press 0.671875
ive 0.0022907257080078125
▁dis 0.91162109375
orders 1.5888671875
. 1.576171875
▁The 1.6962890625
▁question 5.4453125
na 1.0546875
ires 0.00020241737365722656
▁used 2.583984375
▁different 6.87890625
▁variable 8.1640625
▁measures 0.328369140625
▁to 1.8896484375
▁collect 2.57421875
▁information 1.5341796875
. 1.396484375
▁For 1.615234375
▁example 0.2841796875
, 0.001544952392578125
▁it 4.0703125
▁included 1.9580078125
▁compreh 8.2421875
ensive 0.049713134765625
▁so 5.35546875
cio 0.0008764266967773438
- 0.262939453125
dem 0.124267578125
ographic 0.07177734375
▁data 0.90869140625
: 4.953125
▁gender 2.060546875
, 0.042144775390625
▁age 0.278564453125
, 0.036712646484375
▁country 4.203125
, 2.64453125
▁type 4.43359375
▁of 0.06134033203125
▁residence 3.908203125
▁( 2.646484375
urban 0.6865234375
/ 1.3388671875
r 0.156494140625
ural 0.0008363723754882812
), 0.166015625
▁years 6.296875
▁of 0.1649169921875
▁education 0.7412109375
, 0.0870361328125
▁and 1.45703125
▁employ 2.564453125
ment 0.0017042160034179688
▁status 0.6708984375
. 0.1787109375
▁Pat 4.53515625
ients 0.0809326171875
▁were 1.2412109375
▁also 0.9130859375
▁asked 0.5283203125
▁about 0.9541015625
▁their 0.6708984375
▁medical 2.46875
▁history 0.55810546875
▁over 8.6640625
▁the 0.06500244140625
▁years 4.55078125
▁and 1.7109375
▁the 1.4736328125
▁current 2.9453125
▁presence 5.02734375
▁of 0.07843017578125
▁any 2.1796875
▁severe 3.623046875
▁dise 1.859375
ases 7.748603820800781e-05
▁such 4.359375
▁as 0.0009694099426269531
▁heart 2.552734375
▁failure 1.7333984375
, 0.29443359375
▁di 1.5751953125
ab 0.000640869140625
etes 0.0023651123046875
, 0.068115234375
▁ar 4.1015625
th 0.1419677734375
rit 0.0223388671875
is 0.003993988037109375
, 0.025604248046875
▁and 1.197265625
▁so 0.78076171875
▁on 0.05413818359375
. 0.05279541015625
▁In 2.80859375
▁addition 0.52001953125
, 0.1800537109375
▁the 0.755859375
▁record 10.3984375
▁included 1.4033203125
▁a 2.90234375
▁pain 4.76953125
▁measurement 5.1171875
▁scale 0.6982421875
▁from 4.2421875
▁ 0.44970703125
0 0.306396484375
▁to 0.2281494140625
▁ 0.006015777587890625
1 0.06707763671875
0 0.0316162109375
▁to 2.966796875
▁evaluate 1.486328125
▁dis 5.890625
com 0.1005859375
fort 0.0009531974792480469
▁feelings 8.3046875
▁during 4.25390625
▁the 0.33984375
▁last 1.1220703125
▁month 1.7998046875
. 0.2354736328125
▁The 1.3115234375
▁third 6.765625
▁measure 3.59765625
▁of 2.2734375
▁the 0.47412109375
▁question 1.9306640625
naire 0.170654296875
▁was 0.92822265625
▁indicated 11.15625
▁by 1.2646484375
▁information 8.359375
▁on 2.041015625
▁any 4.85546875
▁twelve 14.1640625
- 0.2396240234375
month 0.1307373046875
▁and 5.0703125
▁lifetime 0.66796875
▁drug 3.458984375
▁and 1.7158203125
▁alco 0.126953125
hol 6.079673767089844e-05
▁consumption 4.5859375
. 0.427978515625
▁Among 5.734375
▁all 3.02734375
▁participants 2.041015625
▁in 3.931640625
▁the 0.194091796875
▁study 0.5419921875
, 0.0367431640625
▁ 0.71435546875
4 2.001953125
2 2.341796875
. 1.26171875
2 2.2265625
% 0.059906005859375
▁suffered 4.703125
▁from 0.04931640625
▁de 1.6083984375
pression 0.283203125
, 0.93505859375
▁and 1.3017578125
▁ 0.1273193359375
3 1.5322265625
7 2.3671875
% 2.552734375
▁experienced 2.0625
▁excess 6.8984375
ive 0.0245819091796875
▁anx 0.266357421875
iety 0.0020122528076171875
. 0.442626953125
▁The 1.4345703125
▁pl 10.9921875
ur 0.79931640625
ality 0.0011911392211914062
▁of 0.105712890625
▁de 2.412109375
press 1.2333984375
ive 0.02734375
▁dis 2.134765625
orders 0.07086181640625
▁among 3.048828125
▁patients 1.037109375
▁in 2.8046875
▁the 0.265625
▁op 0.51318359375
i 0.3994140625
ates 0.0015087127685546875
, 9.25
▁medical 4.23828125
▁mar 0.027313232421875
iju 0.0005736351013183594
ana 2.658367156982422e-05
, 0.2296142578125
▁and 0.09429931640625
▁mixed 1.6240234375
▁OP 11.390625
MM 4.2109375
▁groups 0.5625
▁number 9.3046875
ed 0.019256591796875
▁ 0.158203125
5 1.716796875
7 2.61328125
. 0.48779296875
1 2.560546875
%, 0.19091796875
▁ 0.0033130645751953125
2 1.9658203125
2 2.65625
. 0.1019287109375
3 2.2734375
%, 0.0496826171875
▁and 0.053955078125
▁ 0.0017156600952148438
5 2.056640625
1 2.099609375
. 0.154296875
4 1.8935546875
%, 0.1484375
▁respectively 0.0185546875
. 0.255859375
▁The 1.1767578125
▁pl 3.689453125
ur 0.00696563720703125
ality 3.8504600524902344e-05
▁of 0.0216217041015625
▁anx 0.43896484375
iety 0.014801025390625
▁contained 10.9609375
▁ 0.23583984375
4 1.12890625
8 2.35546875
. 0.17041015625
4 2.19921875
% 2.0625
▁among 2.4453125
▁OP 5.28125
▁patients 5.90625
, 0.26318359375
▁ 0.080322265625
2 0.9658203125
1 2.509765625
. 0.10589599609375
5 2.115234375
% 0.0234832763671875
▁among 0.456787109375
▁MM 0.1048583984375
▁patients 0.350341796875
, 0.0179901123046875
▁and 0.014373779296875
▁ 0.0244903564453125
3 1.380859375
8 1.919921875
. 0.125732421875
7 2.2109375
% 0.01157379150390625
▁among 0.1898193359375
▁OP 1.9951171875
MM 0.128662109375
▁participants 3.23828125
. 0.244873046875
▁They 8.0234375
▁were 1.9306640625
▁also 2.12890625
▁an 8.1015625
gu 5.94921875
ished 0.07708740234375
▁em 8.25
otion 0.00615692138671875
ally 0.00595855712890625
▁and 1.9892578125
▁react 7.03125
ed 0.0296173095703125
▁rad 8.9609375
ically 0.00040435791015625
▁neg 5.1875
atively 0.00104522705078125
▁to 0.21875
▁almost 5.78125
▁all 1.2802734375
▁survey 3.79296875
▁questions 0.292724609375
. 0.4208984375
▁Pat 4.3203125
ients 0.01580810546875
▁who 1.912109375
▁took 2.25390625
▁only 2.546875
▁MM 0.91748046875
▁or 2.94140625
▁mixed 2.634765625
▁medic 1.4599609375
ations 0.2335205078125
▁course 13.984375
▁had 2.396484375
▁a 1.6494140625
▁significantly 2.048828125
▁more 4.9140625
▁stable 2.658203125
▁emot 0.73291015625
ional 0.0006623268127441406
▁state 0.60205078125
▁and 1.58984375
▁cop 6.39453125
ed 0.048828125
▁with 0.4609375
▁pain 1.5146484375
▁more 1.85546875
▁manage 6.48828125
able 1.638671875
. 0.54443359375
▁Pat 4.203125
ients 0.009735107421875
▁who 1.2197265625
▁took 1.2861328125
▁strong 9.8046875
▁op 0.8349609375
i 0.6181640625
ates 0.0024261474609375
▁were 2.04296875
▁t 9.015625
ended 0.93603515625
▁to 0.0097503662109375
▁place 9.6328125
▁their 2.28125
▁pain 2.927734375
▁on 1.55078125
▁a 0.5556640625
▁scale 1.7392578125
▁of 0.33642578125
▁ 0.11541748046875
9 2.080078125
▁to 2.140625
▁ 0.011138916015625
1 0.0021038055419921875
0 0.002399444580078125
▁( 3.337890625
Fe 1.0908203125
ing 0.0020885467529296875
old 0.00034046173095703125
▁et 0.016571044921875
▁al 0.0011281967163085938
., 0.00864410400390625
▁ 0.0014400482177734375
2 0.00014019012451171875
0 2.467632293701172e-05
1 0.002117156982421875
7 0.0078125
). 0.00923919677734375
▁One 5.8828125
▁of 0.515625
▁the 0.010528564453125
▁major 2.900390625
▁limitations 2.919921875
▁is 3.212890625
▁the 0.5546875
▁ins 4.62109375
u 0.06341552734375
fficient 0.0679931640625
ly 3.52734375
▁high 3.041015625
▁response 3.158203125
▁rate 0.1036376953125
, 2.63671875
▁ 4.359375
5 1.7431640625
7 2.65234375
% 2.283203125
▁instead 6.1875
▁of 0.0028781890869140625
▁ 0.49365234375
7 1.6455078125
0 0.45556640625
% 1.4765625
▁( 2.482421875
Fe 1.3916015625
ing 0.0017766952514648438
old 0.00032067298889160156
▁et 0.0188446044921875
▁al 0.0002892017364501953
., 0.0082550048828125
▁ 0.001941680908203125
2 0.0001289844512939453
0 9.5367431640625e-05
1 0.0007810592651367188
7 0.005950927734375
). 0.01873779296875
▁It 2.044921875
▁can 3.28515625
▁be 0.650390625
▁fairly 8.25
▁explained 1.7685546875
▁by 0.2210693359375
▁the 0.293701171875
▁weak 7.26171875
▁focus 7.07421875
▁of 0.705078125
▁respond 5.66015625
ents 0.10284423828125
▁who 3.62109375
▁have 3.740234375
▁overcome 8.265625
▁severe 2.078125
▁pain 0.53173828125
▁sens 7.5234375
ations 0.1937255859375
▁and 0.92138671875
▁de 4.76953125
press 0.7587890625
ive 0.044830322265625
▁episodes 2.373046875
. 0.488037109375
▁It 2.814453125
▁is 0.7509765625
▁not 2.498046875
▁clear 3.556640625
▁how 1.943359375
▁to 3.318359375
▁use 4.85546875
▁these 2.66796875
▁statistics 4.07421875
, 3.107421875
▁as 0.7431640625
▁they 1.7783203125
▁still 5.0625
▁may 5.05078125
▁be 1.1953125
▁relevant 6.01953125
▁for 1.771484375
▁the 1.9404296875
▁overall 4.84375
▁analysis 2.5546875
. 0.873046875
